ReviewCurrent oncology reports2019
Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Review in Current oncology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 77 citations in OpenAlex.
- Inspiratory muscle training improves exercise performance and breathing pattern during 6-min walking test in systemic sclerosis-associated interstitial lung disease.ERJ open research · 2026Article
- Orbital Langerhans Cell Histiocytosis in Young Pediatric Patients: Two Case Reports and Literature Review.Pediatric health, medicine and therapeutics · 2026Article
- A case of Langerhans cell histiocytosis localized in the temporal bone, which presented as sudden sensorineural hearing loss: A case report and review of the literature.SAGE open medical case reports · 2026Article
- Whipple Disease Initial Presentation as Supraclavicular Lymphadenopathy in a Patient With Rheumatoid Arthritis: A Diagnostic Challenge.International journal of surgical pathology · 2025Article
- [Clinical analysis of 72 children with Langerhans cell histiocytosis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025Article
- Article
- Beyond BRAFCancer medicine · 2024Article
- Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations.Annals of hematology · 2024Article
- Erdheim‑Chester disease of multisystem involvement with delayed diagnosis: A case report and literature review.Experimental and therapeutic medicine · 2024Article
- Erdheim-Chester Disease: Investigating the Correlation between Targeted Treatment Therapy and Disease Outcomes.Cancers · 2024Article
- Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease.Annals of hematology · 2024Article
- Dermoscopy and reflectance confocal microscopy finding of different anatomic sites of Langerhans cell histiocytosis.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024Article
- Solitary Langerhans cell histiocytosis of the sternum in a 21-year-old woman.Clinical case reports · 2024Article
- The value ofOrphanet journal of rare diseases · 2023Review
- Multisystem ALK-positive histiocytosis: a multi-case study and literature review.Orphanet journal of rare diseases · 2023Review
- Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study.Life (Basel, Switzerland) · 2022Article
- Review
- Molecular and oral manifestations of langerhans cell histiocytosis preceding acute myeloid leukemia.BMC oral health · 2022Article
- Ultrasonographic analysis of Langerhans cell histiocytosis in children: a report of 55 cases.The Journal of international medical research · 2022Article
- The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.Leukemia · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewProvide an overview of recent progress in decoding the pathogenesis and treatment of systemic histiocytoses. RECENT
findingsAdvances in molecular techniques over the last few years, enabling the identification of several MAPK mutations in lesion histiocytes, have revolutionized our understanding of histiocytosis that led to a revised classification and new treatments. Since the 2010 discovery of the BRAF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.